1-6 of 6
Marc R. Mansour, MD PhD
Close
Sort by
Journal Articles

Aging of Preleukemic Thymocytes Drives CpG Island Hypermethylation in T-Cell Acute Lymphoblastic Leukemia

Juliette Roels, Morgan Thénoz, Bronisława Szarzyńska, Mattias Landfors, Stien De Coninck, Lisa Demoen, Lien Provez, Anna Kuchmiy, Steven Strubbe, Lindy Reunes, Tim Pieters, PhD, Filip Matthijssens, PhD, Wouter Van Loocke, Tim Lammens, PhD, Barbara De Moerloose, MD PhD, Marc R. Mansour, MD PhD, Utpal Dave, MD, Steven Goossens, PhD, David J. Curtis, MBBS,PhD, Tom Taghon, PhD, Małgorzata Dawidowska, PhD, Sofie Degerman, PhD, Pieter Van Vlierberghe, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 28–29.
https://doi.org/10.1182/blood-2020-138501
Published: 2020
Journal Articles

Utility of FDG-PET/CT in Lymphoblastic Lymphoma

Thomas A Fox, BSc, MSc, MRCP, Ben Carpenter, PhD, Asim Khwaja, Richard Halsey, MRCP, Victoria Grandage, Marc R. Mansour, MD PhD FRCPath, Adele K. Fielding, MBBS,PhDFRCP,FRCPath, Rachael E Hough, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2890.
https://doi.org/10.1182/blood-2019-127379
Published: 2019
Journal Articles

Synthetic Lethal Screening Identifies CHK1 Inhibition As an Exploitable Vulnerability in EZH2 Deficient T-ALL

Theresa E. Leon, PhD MSc, BSc, Tanya Rapoz-D'Silva, BSc, MSc, Sunniyat Rahman, MBiochem, DIC, PhD, Michael Magnussen, BSc, MSc, Nadine Farah, MBBChir, MA, MRCP, FRCPath, Jose A. Guerra-Assunção, BSc, PhD, Rajeev Gupta, MB.ChB, PhD FRCP, FRCPath, Elisabeth P. Nacheva, MD PhD, Javier Herrero, PhD, David C. Linch, FRCP, Marc R. Mansour, MD PhD FRCPath
Journal: Blood
Blood (2017) 130 (Supplement 1): 1325.
https://doi.org/10.1182/blood.V130.Suppl_1.1325.1325
Published: 2017
Journal Articles

Targeting Oncogenic Interleukein-7 Receptor Signaling With N-Acetylcysteine In T-Cell Acute Lymphoblastic Leukemia

Marc R. Mansour, MD PhD FRCPath, Casie Reed, Amy Eisenberg, Jen-Chieh Tseng, PhD, Akinori Yoda, PhD, Scott J Rodig, MD, PhD, Daniel J. DeAngelo, MD, Ph.D, Stephen E. Sallan, MD, David M. Weinstock, MD, Shai Izraeli, MD, Andrew L Kung, MD, PhD, Alex Kentsis, MD, PhD, Thomas Look, MD
Journal: Blood
Blood (2013) 122 (21): 2535.
https://doi.org/10.1182/blood.V122.21.2535.2535
Published: 2013
Journal Articles

HSP90 Inhibition Has Potent Activity Against T-Cell Acute Lymphoblastic Leukemia (T-ALL) Through Degradation Of TYK2 Kinase

Koshi Akahane, Takaomi Sanda, PhD, Marc R. Mansour, MD PhD FRCPath, Julia Etchin, PhD, Ng Cherry, David M. Weinstock, MD, Anthony Letai, MD, PhD, Daniel J. DeAngelo, MD, Ph.D, A. Thomas Look, MD
Journal: Blood
Blood (2013) 122 (21): 2528.
https://doi.org/10.1182/blood.V122.21.2528.2528
Published: 2013
Journal Articles

A Genetic Screen In Zebrafish Identified Dlst As a Potential Therapeutic Target For Human Acute T-Lymphoblastic Leukemia

Nicole M Anderson, PhD, Hongling Peng, MD, Daniel Helman, BS, Itrat Harrold, PhD, Takaomi Sanda, PhD, Trevor Grant, MS, Nicholas Nagykery, BS, Yasmina Samaha, Meng Le, PhD, Adam Amsterdam, PhD, Donna Neuberg, ScD, Marc R. Mansour, MD PhD FRCPath, Travis Denton, PhD, John Kanki, PhD, Anurag Singh, PhD, A. Thomas Look, MD, Hui Feng, PhD
Journal: Blood
Blood (2013) 122 (21): 1273.
https://doi.org/10.1182/blood.V122.21.1273.1273
Published: 2013